Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if IMA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
11 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 86 days ago
Red flags: 5
35 filers reported a long position in IMA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BVF INC/IL | $6.5M | 1.1M | Unchanged |
| Blue Owl Capital Holdings LP | $5.4M | 917.7K | -4.3% |
| ORBIMED ADVISORS LLC | $5.4M | 909.3K | +140.2% |
| Cable Car Capital, LP | $4.6M | 781.6K | +3.6% |
| Omega Fund Management, LLC | $2.7M | 455.4K | Unchanged |
| RTW INVESTMENTS, LP | $2M | 334.4K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.9M | 320.5K | -1.4% |
| Trails Edge Capital Partners, LP | $1.7M | 282K | New |
| BML Capital Management, LLC | $1.2M | 200.7K | Unchanged |
| Monashee Investment Management LLC | $1.1M | 192.3K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.